logo

For the Inventor, By the Inventor

Eastgate Village, Eastgate Little Island, Co Cork, Ireland

Tibotec Pharmaceuticals Ltd.

Calculating rank
USPTO Granted Patents = 67

% Expired Patents = 59.7



Trademarks = 3

Forward Citations = 274

Loading Chart...
Loading Chart...

142 inventors (with patents filed for the assignee):

goldMedal Herman Augustinus De Kock (19 out of 36 patents)

silverMedal Dominique Louis Nestor Ghislain Surleraux (18 out of 32 patents)

bronzeMedal Abdellah Tahri (13 out of 61 patents)

4.  Pierre Jean-Marie Bernard Raboisson (13 out of 178 patents)

5.  Piet Tom Bert Paul Wigerinck (12 out of 24 patents)

6.  Sandrine Marie Helene Vendeville (11 out of 41 patents)

7.  Kenneth Simmen (10 out of 26 patents)

8.  Marie-Pierre T M M G De Bethune (8 out of 10 patents)

9.  Bart Rudolf Romanie Kesteleyn (7 out of 37 patents)

10.  Jean-François Bonfanti (6 out of 45 patents)

11.  Wim Gaston Verschueren (6 out of 32 patents)

12.  Jerôme Emile Georges Guillemont (6 out of 27 patents)

13.  Åsa Annica Kristina Rosenquist (6 out of 18 patents)

14.  Karl Magnus Nilsson (6 out of 18 patents)

15.  Lili Hu (5 out of 37 patents)


Core Competencies:
HIV
Protease Inhibitors
Macrocyclic Compounds
Pyrimidine Derivatives
Hepatitis C
Benzimidazoles
Drug Resistance
Viral Replication

67 patents:

1. 8916558 - Powders for reconstitution (2014-12-23),
2. 8618291 - Process for preparing 4-[(1,6-dihydro-6-OXO-2-pyrimidinyl)amino]benzonitrile (2013-12-31),
3. 8575342 - HIV inhibiting 5-heterocyclyl pyrimidines (2013-11-05),
4. 8546076 - Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistance (2013-10-01),
5. 8426434 - Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile (2013-04-23),
6. 8357687 - Macrocyclic indole derivatives useful as hepatitis C virus inhibitors (2013-01-22),
7. 8349869 - Macrocylic inhibitors of hepatitis C virus (2013-01-08),
8. 8285666 - Phenotype prediction method (2012-10-09),
9. 8183394 - Protease inhibitor precursor synthesis (2012-05-22),
10. 8183277 - Macrocylic inhibitors of hepatitis C virus (2012-05-22),
11. 8178694 - Heterocyclylaminoalkyl substituted benzimidazoles (2012-05-15),
12. 8163745 - HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines (2012-04-24),
13. 8153800 - Macrocyclic inhibitors of hepatitis C virus (2012-04-10),
14. 8153640 - HIV inhibiting bicyclic pyrimdine derivatives (2012-04-10),
15. 8148399 - Macrocyclic inhibitors of hepatitis C virus (2012-04-03),
Company Overview
Tibotec Pharmaceuticals Ltd. is a biopharmaceutical company based in Eastgate Village, Co Cork, Ireland, specializing in the development of innovative therapies for HIV and related viral infections. The company focuses on advanced drug development, particularly in the areas of protease inhibitors and macrocyclic compounds, addressing challenges such as drug resistance and viral replication. Tibotec's research also extends to hepatitis C, utilizing a range of chemical classes including pyrimidine derivatives and benzimidazoles to enhance treatment options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Tibotec Pharmaceuticals Ltd. USPTO Patent Assignee Logo
67 Patents

#1 in Eastgate Village, Eastgate Little Island, Co Cork

#45 in Ireland

#11,046 in the World

Eastgate Village, Eastgate Little Island, Co Cork, IE
Eastgate Village, Eastgate Little Island, Co Cork, Ireland

Tibotec Pharmaceuticals Ltd.

Forward Citations = 274

142 inventors:

goldMedal Herman Augustinus De Kock (19 out of 36 patents)

silverMedal Dominique Louis Nestor Ghislain Surleraux (18 out of 32 patents)

bronzeMedal Abdellah Tahri (13 out of 61 patents)

4.  Pierre Jean-Marie Bernard Raboisson (13 out of 178 patents)

5.  Piet Tom Bert Paul Wigerinck (12 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tibotec Pharmaceuticals Ltd.. Retrieved from https://idiyas.com/company/tibotec-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…